(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.07%) $0.927
(0.07%) $10.85
(-0.04%) $0.792
(-0.03%) $92.55
0.39% KRW 5 160.00
Live Chart Being Loaded With Signals
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants...
Stats | |
---|---|
Today's Volume | 21 940.00 |
Average Volume | 521 586 |
Market Cap | 83.50B |
EPS | KRW0 ( 2023-09-30 ) |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW16.34 (0.32%) |
Volume Correlation
Yuyu Pharma, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Yuyu Pharma, Inc. Correlation - Currency/Commodity
Yuyu Pharma, Inc. Financials
Annual | 2023 |
Revenue: | KRW137.21B |
Gross Profit: | KRW46.51B (33.89 %) |
EPS: | KRW-441.41 |
Q4 | 2023 |
Revenue: | KRW34.61B |
Gross Profit: | KRW10.67B (30.82 %) |
EPS: | KRW-67.14 |
Q3 | 2023 |
Revenue: | KRW34.09B |
Gross Profit: | KRW11.20B (32.87 %) |
EPS: | KRW-167.60 |
Q2 | 2023 |
Revenue: | KRW34.22B |
Gross Profit: | KRW12.54B (36.66 %) |
EPS: | KRW-213.76 |
Financial Reports:
No articles found.
Yuyu Pharma, Inc.
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators